Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

593-615 (Activation loop from InterPro)

Target domain

453-711 (Protein kinase domain)

Relief mechanism

Assay

Autoinhibited structure

Activated structure

7 structures for Q13237

Entry ID Method Resolution Chain Position Source
5BV6 X-ray 194 A A 269-418 PDB
5C6C X-ray 205 A A/B 137-277 PDB
5C8W X-ray 180 A A/B/C/D/E/F 137-277 PDB
5JIX X-ray 147 A A 269-418 PDB
5JIZ X-ray 150 A A 269-418 PDB
6BQ8 Other 200 A A 269-418 PDB
AF-Q13237-F1 Predicted AlphaFoldDB

463 variants for Q13237

Variant ID(s) Position Change Description Diseaes Association Provenance
VAR_086537 569 R>del AMD4; decreased protein abundance; unable to phosphorylate RAF1 in response to FGF2 and to inhibit FGF2-induced MAPK signaling; unable to suppress SOX9-induced COL2A1 expression; unable to upregulate COL10A1 [UniProt] Yes UniProt
CA99612799
rs901413158
2 G>V No ClinGen
Ensembl
rs1560628921
CA357162219
4 G>D No ClinGen
Ensembl
rs1401276949
CA357162206
6 V>E No ClinGen
Ensembl
CA357162210
rs1560628906
6 V>M No ClinGen
Ensembl
CA2984035
rs551494338
8 P>R No ClinGen
1000Genomes
ExAC
gnomAD
rs549621974
CA99612791
9 K>R No ClinGen
1000Genomes
TOPMed
CA2984034
rs139093432
10 H>R No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA357162158
rs757688228
13 H>Q No ClinGen
ExAC
TOPMed
gnomAD
rs781488557
CA2984033
13 H>Y No ClinGen
ExAC
TOPMed
gnomAD
CA357162154
rs1377821319
14 P>L No ClinGen
gnomAD
rs747364669
CA2984031
14 P>S No ClinGen
ExAC
gnomAD
CA2984029
rs754590954
15 D>N No ClinGen
ExAC
gnomAD
COSM588360
CA357162150
rs754590954
COSM588359
15 D>Y lung [Cosmic] No ClinGen
cosmic curated
ExAC
gnomAD
rs765708325
CA99612741
17 H>R No ClinGen
Ensembl
rs755518936
CA2984026
18 S>C No ClinGen
ExAC
TOPMed
gnomAD
rs192577898
CA2984025
19 G>R No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA357162112
rs963315125
21 L>F No ClinGen
TOPMed
gnomAD
rs963315125
CA99612730
21 L>V No ClinGen
TOPMed
gnomAD
rs34956759
CA99612723
22 T>I No ClinGen
Ensembl
CA99612725
VAR_051633
rs34956759
22 T>S No ClinGen
UniProt
Ensembl
dbSNP
CA99612714
rs916856737
23 T>A No ClinGen
TOPMed
rs148254773
CA2984022
23 T>S No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA2984021
rs763941574
24 D>G No ClinGen
ExAC
gnomAD
rs763941574
CA99612690
24 D>V No ClinGen
ExAC
gnomAD
rs1486763048
CA357162099
24 D>Y No ClinGen
gnomAD
CA2984017
rs183060437
27 R>Q No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
COSM481578
COSM481577
CA2984018
rs187350442
27 R>W Variant assessed as Somatic; 0.0002314 impact. kidney large_intestine urinary_tract [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
1000Genomes
ESP
ExAC
NCI-TCGA
TOPMed
gnomAD
CA357162076
rs1355655926
28 N>S No ClinGen
gnomAD
CA2984015
rs777257586
29 K>E No ClinGen
ExAC
gnomAD
CA99612664
rs1032955278
29 K>R No ClinGen
TOPMed
CA357162065
rs771410076
CA2984014
30 V>L No ClinGen
ExAC
gnomAD
rs771410076
CA357162066
30 V>M No ClinGen
ExAC
gnomAD
CA99612650
rs966676731
31 T>I No ClinGen
TOPMed
gnomAD
CA2984012
rs759299128
34 E>K No ClinGen
ExAC
TOPMed
gnomAD
rs547943840
CA2984011
39 R>K No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs528256766
CA2984010
43 E>D No ClinGen
1000Genomes
ExAC
gnomAD
CA357161961
rs1200953365
45 Q>R No ClinGen
TOPMed
rs966786904
CA99612607
46 E>G No ClinGen
Ensembl
rs1418761850
CA357161957
46 E>K No ClinGen
gnomAD
CA99612590
rs199612321
47 R>L Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
ESP
ExAC
NCI-TCGA
TOPMed
gnomAD
rs199612321
COSM3409571
CA2984005
COSM3409572
47 R>Q Variant assessed as Somatic; 0.0 impact. central_nervous_system [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
ESP
ExAC
NCI-TCGA
TOPMed
gnomAD
CA2984006
rs369304947
47 R>W No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
CA99612588
rs368293735
50 H>N No ClinGen
Ensembl
rs1488090708
CA357161930
50 H>R No ClinGen
gnomAD
CA357161924
rs1560628512
51 L>V No ClinGen
Ensembl
CA357161903
rs1234522253
53 E>D No ClinGen
gnomAD
TCGA novel 53 E>Q Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA357161905
rs1271233219
53 E>V No ClinGen
gnomAD
rs143773305
CA99612586
54 L>V No ClinGen
ESP
rs763996547
CA357161896
55 R>L No ClinGen
ExAC
TOPMed
gnomAD
rs763996547
CA2984002
55 R>Q No ClinGen
ExAC
TOPMed
gnomAD
CA2984003
rs138293539
55 R>W No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs901059775
CA99612576
56 E>G No ClinGen
Ensembl
CA2984000
rs753033493
57 Q>E No ClinGen
ExAC
gnomAD
rs573862255
CA2983999
57 Q>R No ClinGen
1000Genomes
ExAC
gnomAD
CA2983998
rs759714578
58 L>M No ClinGen
ExAC
gnomAD
CA2983997
rs543931109
59 S>L No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
TCGA novel 59 S>P Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
TCGA novel 60 K>* Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs770954502
CA2983996
60 K>E No ClinGen
ExAC
gnomAD
TCGA novel 60 K>M Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
TCGA novel 62 T>S Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1278472990
CA357161834
65 I>M No ClinGen
gnomAD
CA357161829
rs1307252887
66 A>D No ClinGen
TOPMed
rs1240056510
CA357161833
66 A>T No ClinGen
TOPMed
CA2983995
rs772997158
72 L>F No ClinGen
ExAC
gnomAD
CA2983994
rs371926830
75 K>R Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ESP
ExAC
NCI-TCGA
TOPMed
gnomAD
CA2983993
rs772427647
77 I>V No ClinGen
ExAC
gnomAD
CA357161727
rs1468912770
81 K>E No ClinGen
gnomAD
rs1193625346
CA357161690
86 V>A No ClinGen
gnomAD
CA357161692
rs1256836464
86 V>M No ClinGen
gnomAD
rs1228525457
CA357161684
87 H>R No ClinGen
gnomAD
CA2983992
rs748455274
87 H>Y No ClinGen
ExAC
TOPMed
gnomAD
rs1301770630
CA357161677
88 M>T No ClinGen
TOPMed
gnomAD
rs1007254791
CA99612545
88 M>V No ClinGen
gnomAD
CA2983991
rs779814922
89 Q>E No ClinGen
ExAC
gnomAD
CA357161657
rs1466542604
91 G>R No ClinGen
TOPMed
gnomAD
rs769307657
CA357161647
92 S>R No ClinGen
ExAC
gnomAD
CA2983989
rs147037183
93 P>L No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
TCGA novel 94 L>F Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1176638156
CA357161634
95 Q>* Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
rs1239469098
CA357161626
96 A>T Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
rs751548718
CA2983986
97 S>F No ClinGen
ExAC
TOPMed
gnomAD
rs1434403074
CA357161614
98 P>A No ClinGen
gnomAD
rs369603303
CA99612526
98 P>L No ClinGen
ESP
TOPMed
rs1434403074
CA357161613
98 P>S No ClinGen
gnomAD
rs777851898
CA2983985
99 D>Y No ClinGen
ExAC
gnomAD
rs1047503891
CA99612505
101 V>M No ClinGen
TOPMed
rs1195310629
CA357161588
102 P>S No ClinGen
TOPMed
gnomAD
rs34616910
CA2983983
VAR_040608
106 H>R No ClinGen
UniProt
ExAC
dbSNP
gnomAD
rs759704753
CA2983981
COSM2955320
COSM2955321
107 R>Q central_nervous_system [Cosmic] No ClinGen
cosmic curated
ExAC
gnomAD
CA2983982
rs375411166
107 R>W No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs918352690
CA99612497
110 S>P No ClinGen
Ensembl
rs1446716035
CA357161523
112 L>F No ClinGen
TOPMed
rs766457660
CA2983979
114 S>C No ClinGen
ExAC
gnomAD
CA357161507
rs1422251937
115 L>P No ClinGen
gnomAD
rs577248170
CA2983977
116 H>R No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs1375660918
CA357161493
117 S>I No ClinGen
TOPMed
CA357161417
rs1320186063
129 P>A No ClinGen
TOPMed
rs769016833
CA2983973
132 R>Q No ClinGen
ExAC
TOPMed
gnomAD
CA2983974
rs774548154
132 R>W No ClinGen
ExAC
TOPMed
gnomAD
CA357161378
rs1560628014
135 D>V No ClinGen
Ensembl
CA357161375
rs1317000168
136 L>V No ClinGen
TOPMed
rs1560627989
CA357161369
137 N>D No ClinGen
Ensembl
CA2983971
rs780927194
139 P>A No ClinGen
ExAC
gnomAD
rs770633181
CA357161352
139 P>H No ClinGen
ExAC
TOPMed
gnomAD
rs770633181
CA2983970
139 P>L No ClinGen
ExAC
TOPMed
gnomAD
rs770633181
CA357161351
139 P>R No ClinGen
ExAC
TOPMed
gnomAD
rs1256717141
CA357161349
140 P>A No ClinGen
TOPMed
gnomAD
CA357161346
rs991077506
140 P>L No ClinGen
TOPMed
gnomAD
CA99612461
rs991077506
140 P>R No ClinGen
TOPMed
gnomAD
CA357161338
rs1578523827
141 E>D No ClinGen
Ensembl
rs867660938
CA99612458
143 S>F Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
Ensembl
NCI-TCGA
CA357161300
rs1156755719
147 A>T No ClinGen
gnomAD
rs746507687
CA2983969
147 A>V No ClinGen
ExAC
gnomAD
CA357161265
rs1578523781
152 D>N No ClinGen
Ensembl
CA99598255
rs922114447
157 K>Q No ClinGen
TOPMed
rs1444179826
CA357160559
157 K>R No ClinGen
TOPMed
CA357160558
rs1444179826
157 K>T No ClinGen
TOPMed
rs746562652
CA2983951
159 I>V No ClinGen
ExAC
gnomAD
TCGA novel 161 D>N Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
TCGA novel 161 D>Y Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1386860638
CA357160526
162 A>S No ClinGen
TOPMed
rs772633886
CA2983950
163 L>F No ClinGen
ExAC
gnomAD
rs1384290948
CA357160497
166 N>S No ClinGen
TOPMed
gnomAD
CA357160489
rs1329254646
167 Q>R No ClinGen
gnomAD
CA99598247
rs199920901
171 R>S No ClinGen
1000Genomes
rs748046133
CA2983948
173 D>E No ClinGen
ExAC
gnomAD
rs771558283
CA2983949
173 D>G No ClinGen
ExAC
gnomAD
CA357160451
rs1352627711
173 D>Y No ClinGen
TOPMed
rs1443783392
CA357160445
174 P>S No ClinGen
TOPMed
rs778839928
CA2983947
176 Q>E No ClinGen
ExAC
gnomAD
CA357160413
rs1465001126
178 K>N No ClinGen
gnomAD
rs754794041
CA2983946
179 D>N No ClinGen
ExAC
gnomAD
CA2983945
rs145769252
180 M>I No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
CA357160372
rs1381652208
184 M>L No ClinGen
TOPMed
rs1169406430
CA357160370
184 M>T No ClinGen
TOPMed
gnomAD
rs750603065
CA2983942
186 G>R No ClinGen
ExAC
gnomAD
rs752074471
CA2983939
189 Y>C Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
rs867102677
CA99598190
190 Q>* No ClinGen
gnomAD
rs1185102778
CA357160328
190 Q>P No ClinGen
gnomAD
rs1249124858
CA357160307
193 S>C No ClinGen
gnomAD
rs763463028
CA2983937
193 S>I No ClinGen
ExAC
gnomAD
rs1467576675
CA357160301
194 Y>H No ClinGen
gnomAD
rs1560603331
CA357160270
198 Q>* No ClinGen
Ensembl
CA2983934
rs772859724
201 P>S No ClinGen
ExAC
gnomAD
CA2983933
rs772859724
201 P>T No ClinGen
ExAC
gnomAD
CA2983932
rs141031882
204 H>R No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs866256614
CA99598145
204 H>Y No ClinGen
Ensembl
CA357160196
rs1306226278
209 A>G No ClinGen
TOPMed
CA357160166
rs1488021301
212 R>Q No ClinGen
TOPMed
TCGA novel 214 E>* Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA2983909
rs775339041
215 V>M No ClinGen
ExAC
gnomAD
CA2983908
rs769644668
216 F>I No ClinGen
ExAC
gnomAD
rs376913619
CA2983907
216 F>L No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA357160135
rs1419074058
217 Q>R No ClinGen
gnomAD
CA2983906
rs566711398
218 G>R No ClinGen
1000Genomes
ExAC
gnomAD
rs985488263
CA99596801
221 L>S No ClinGen
Ensembl
rs961166144
CA99596798
224 S>C No ClinGen
TOPMed
gnomAD
rs1208380099
CA357160076
226 P>L No ClinGen
gnomAD
rs747161506
CA2983904
227 M>R No ClinGen
ExAC
gnomAD
COSM448208
CA357160074
rs1486539212
COSM448209
227 M>V Variant assessed as Somatic; 0.0 impact. breast [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
NCI-TCGA
gnomAD
CA99596788
rs953247501
228 W>C No ClinGen
Ensembl
TCGA novel 229 T>I Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA2983901
rs753257317
234 L>F No ClinGen
ExAC
gnomAD
rs151098655
CA99596769
239 N>H No ClinGen
ESP
TOPMed
rs755449431
CA2983899
239 N>T No ClinGen
ExAC
gnomAD
CA357159965
rs1455368632
240 C>R No ClinGen
TOPMed
CA2983897
rs767113787
241 T>A No ClinGen
ExAC
gnomAD
CA99596749
rs959153317
243 T>A No ClinGen
TOPMed
TCGA novel 248 A>D Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA99595998
rs1054269497
250 T>S No ClinGen
Ensembl
rs934497779
CA99595997
251 N>S No ClinGen
TOPMed
gnomAD
CA357159733
rs1578460743
253 K>N No ClinGen
Ensembl
TCGA novel 254 T>I Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1452689852
CA357159722
255 W>* No ClinGen
TOPMed
CA357159710
rs1458284600
257 L>I No ClinGen
TOPMed
gnomAD
CA2983881
rs779609767
259 R>* No ClinGen
ExAC
gnomAD
rs180794545
CA2983880
261 V>I No ClinGen
1000Genomes
ExAC
gnomAD
CA357159674
rs1192148070
262 F>L No ClinGen
gnomAD
rs367712750
CA99595973
266 M>T No ClinGen
gnomAD
TCGA novel 267 R>W Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA2983877
rs756375957
268 R>K No ClinGen
ExAC
CA2983875
rs146408307
270 A>V No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA357159599
rs1391431769
273 R>I No ClinGen
TOPMed
rs757954080
CA99595958
274 D>E No ClinGen
ExAC
TOPMed
gnomAD
CA2983873
rs752173745
276 Q>R No ClinGen
ExAC
gnomAD
CA357159557
rs1306039853
279 N>H No ClinGen
TOPMed
rs759542953
CA2983871
279 N>I No ClinGen
ExAC
TOPMed
gnomAD
CA2983870
rs143992630
281 L>F No ClinGen
ESP
ExAC
gnomAD
rs1328348075
CA357159502
285 S>F No ClinGen
gnomAD
rs924960171
CA99595046
285 S>P No ClinGen
Ensembl
COSM263109
rs144720151
COSM263110
CA2983849
288 K>N Variant assessed as Somatic; 0.0 impact. large_intestine [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
1000Genomes
ExAC
NCI-TCGA
TOPMed
gnomAD
TCGA novel 294 K>T Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1433874038
CA357159429
296 T>A No ClinGen
TOPMed
gnomAD
CA357159427
rs1263265315
296 T>I No ClinGen
TOPMed
TCGA novel 297 K>N Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs768785908
CA2983846
299 I>V No ClinGen
ExAC
CA2983845
rs762927878
300 D>Y No ClinGen
ExAC
gnomAD
rs867286988
CA99595029
303 E>* No ClinGen
Ensembl
rs1478355961
CA357159376
303 E>D No ClinGen
gnomAD
CA2983843
rs770168040
304 V>M No ClinGen
ExAC
gnomAD
CA357164759
rs1560584673
306 Y>H No ClinGen
Ensembl
rs1186764754
CA357164749
307 Y>C No ClinGen
TOPMed
gnomAD
CA357164742
rs1171371884
308 D>A No ClinGen
gnomAD
rs778680190
CA2983818
312 Y>C No ClinGen
ExAC
gnomAD
rs747364743
CA2983819
312 Y>N No ClinGen
ExAC
gnomAD
rs778680190
CA357164713
312 Y>S No ClinGen
ExAC
gnomAD
rs1443459138
CA357164707
313 I>F No ClinGen
gnomAD
CA99639764
rs866664833
313 I>T No ClinGen
Ensembl
TCGA novel 313 I>V Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA99639763
rs1052242872
314 I>V No ClinGen
Ensembl
CA357164680
rs1206839034
317 G>C No ClinGen
TOPMed
gnomAD
CA357164677
rs1203601013
COSM1291969
COSM1291968
317 G>V haematopoietic_and_lymphoid_tissue [Cosmic] No ClinGen
cosmic curated
TOPMed
CA2983817
rs768165134
318 E>K Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
CA357164664
rs1353855899
319 E>V No ClinGen
gnomAD
rs144485448
CA2983816
320 G>R No ClinGen
ESP
ExAC
gnomAD
CA357164653
rs1448519875
321 S>N No ClinGen
TOPMed
gnomAD
rs1481420599
CA357164642
323 F>V No ClinGen
TOPMed
CA357164633
rs1178935850
324 F>L No ClinGen
TOPMed
rs1325712223
CA357164627
324 F>L No ClinGen
gnomAD
rs1316143630
CA357164626
325 I>V No ClinGen
gnomAD
TCGA novel 329 G>* Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1388725896
CA357164587
330 K>M No ClinGen
gnomAD
rs1248584655
CA357164572
331 V>I No ClinGen
gnomAD
CA2983798
rs775142753
332 K>Q No ClinGen
ExAC
TOPMed
gnomAD
rs1272181329
CA357164535
336 S>N No ClinGen
TOPMed
gnomAD
CA357164525
rs1344204545
338 E>K No ClinGen
gnomAD
rs1240131166
CA357164515
339 G>C No ClinGen
TOPMed
rs745358480
CA357164513
339 G>D No ClinGen
ExAC
TOPMed
gnomAD
CA2983796
rs745358480
339 G>V No ClinGen
ExAC
TOPMed
gnomAD
rs149280984
CA2983794
340 H>R No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs746914865
CA2983793
341 D>H No ClinGen
ExAC
TOPMed
gnomAD
CA99638380
rs76774487
342 Q>K No ClinGen
Ensembl
rs947620733
CA99638376
342 Q>R No ClinGen
TOPMed
TCGA novel 344 Q>R Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA357164457
rs1457342227
348 T>A No ClinGen
TOPMed
rs753019548 348 T>H Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No NCI-TCGA
CA2983791
rs758141863
348 T>I No ClinGen
ExAC
TCGA novel 349 L>P Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs752925020
CA357164452
349 L>V No ClinGen
ExAC
TOPMed
gnomAD
rs1002598743
CA99638332
350 Q>R No ClinGen
TOPMed
CA357164428
rs1368343110
352 G>A No ClinGen
gnomAD
TCGA novel 357 E>* Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1432017643
CA357164376
359 A>V No ClinGen
gnomAD
rs1023017879
CA99638301
360 L>F No ClinGen
Ensembl
rs889657210
CA99636749
364 D>N No ClinGen
Ensembl
CA357164326
rs1179123431
365 V>D No ClinGen
gnomAD
TCGA novel 374 E>* Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
TCGA novel 375 N>I Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA99636746
rs1026716873
382 I>V No ClinGen
Ensembl
CA357164202
rs1288738398
383 D>G No ClinGen
TOPMed
rs769858245
CA2983770
384 R>* Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
CA357164199
rs769858245
384 R>G No ClinGen
ExAC
TOPMed
gnomAD
TCGA novel 386 T>K Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1246608314
CA357164158
388 N>S No ClinGen
gnomAD
rs1313936811
CA357164132
392 G>S No ClinGen
gnomAD
rs1315872987
CA357164106
396 E>* No ClinGen
TOPMed
gnomAD
CA2983751
rs768386011
400 Y>C No ClinGen
ExAC
TOPMed
gnomAD
TCGA novel 400 Y>I Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA357164073
rs768386011
400 Y>S No ClinGen
ExAC
TOPMed
gnomAD
CA357164022
rs780252159
408 L>V No ClinGen
ExAC
TOPMed
gnomAD
CA2983747
rs147205318
410 R>C No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs781091224
CA2983746
410 R>H No ClinGen
ExAC
TOPMed
gnomAD
CA2983748
rs147205318
410 R>S No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA357164002
rs1257158457
411 D>G No ClinGen
TOPMed
gnomAD
rs1257158457
CA357164001
411 D>V No ClinGen
TOPMed
gnomAD
TCGA novel 415 R>K Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs112801782 417 A>= Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No NCI-TCGA
CA2983743
rs764556712
417 A>G No ClinGen
ExAC
TOPMed
gnomAD
CA357163957
rs1167779908
417 A>T No ClinGen
gnomAD
CA99633324
rs764556712
417 A>V No ClinGen
ExAC
TOPMed
gnomAD
CA2983715
rs767062078
419 R>Q No ClinGen
ExAC
gnomAD
CA2983716
rs749988308
419 R>W No ClinGen
ExAC
gnomAD
CA357163931
rs1415354794
420 S>P No ClinGen
TOPMed
rs1173754885
CA357163926
421 M>V No ClinGen
gnomAD
CA2983712
rs763997624
422 S>F No ClinGen
ExAC
TOPMed
gnomAD
rs775376307
CA2983710
427 S>Y No ClinGen
ExAC
gnomAD
CA357163877
rs1383742417
428 K>Q No ClinGen
TOPMed
rs1254385275
CA357163873
428 K>R No ClinGen
TOPMed
gnomAD
CA2983708
rs138211185
429 A>T No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA2983707
rs776712275
430 L>F No ClinGen
ExAC
gnomAD
rs537692247
CA357163855
431 S>C No ClinGen
1000Genomes
gnomAD
rs537692247
CA99632317
431 S>F No ClinGen
1000Genomes
gnomAD
TCGA novel 433 E>W Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA357163831
rs1267631846
435 I>V No ClinGen
gnomAD
rs778460125
CA2983704
438 K>Q No ClinGen
ExAC
gnomAD
rs953313156
CA99632295
441 V>M No ClinGen
TOPMed
COSM1694602
CA357163758
COSM1694601
rs1212201931
445 S>F skin [Cosmic] No ClinGen
cosmic curated
TOPMed
CA2983702
rs200933391
446 S>A No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs1415041514
CA357163735
449 P>L No ClinGen
gnomAD
rs147027279
CA2983699
453 L>F No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA2983698
rs767064866
455 I>F No ClinGen
ExAC
gnomAD
CA2983697
rs756811534
457 A>T No ClinGen
ExAC
TOPMed
gnomAD
CA357163657
rs1157938978
461 V>G No ClinGen
TOPMed
rs1435469465
CA357163662
461 V>I No ClinGen
TOPMed
TCGA novel 466 R>I Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1185390240
CA357163611
468 E>D No ClinGen
gnomAD
CA2983670
rs370764328
484 I>L No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA99630821
rs370764328
484 I>V No ClinGen
ESP
ExAC
TOPMed
gnomAD
TCGA novel 485 R>M Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
TCGA novel 489 I>T Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA357163413
rs1317206242
494 Q>R No ClinGen
gnomAD
CA2983667
rs761789084
499 Y>H No ClinGen
ExAC
TOPMed
gnomAD
rs1436560351
CA357163370
500 S>P No ClinGen
TOPMed
CA99630789
rs939124305
502 K>R No ClinGen
Ensembl
rs774972977
CA2983666
503 R>K No ClinGen
ExAC
TOPMed
gnomAD
rs201921306
CA99630757
503 R>S No ClinGen
Ensembl
CA357163292
rs1366494333
510 S>C No ClinGen
TOPMed
CA2983664
rs373273232
515 K>Q No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs1313433626
CA357162784
517 Y>H No ClinGen
gnomAD
CA2983644
rs148306160
518 R>C No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA2983643
rs371262558
518 R>H No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
TCGA novel 521 K>N Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA357162745
rs1244720720
522 D>E No ClinGen
gnomAD
TCGA novel 522 D>N Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs772888849
CA2983642
523 N>S No ClinGen
ExAC
TOPMed
gnomAD
rs1286809657
CA357162729
524 K>N No ClinGen
gnomAD
CA2983641
rs143281279
525 Y>C No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA99628292
rs143281279
525 Y>F Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
ESP
ExAC
NCI-TCGA
TOPMed
gnomAD
CA357162706
rs1302764465
528 M>L No ClinGen
TOPMed
gnomAD
rs146605505
COSM1671103
CA99628274
COSM1671102
534 L>V ovary [Cosmic] No ClinGen
cosmic curated
ESP
ExAC
TOPMed
gnomAD
rs1177307199
CA357162657
535 G>D No ClinGen
gnomAD
CA2983636
rs780130091
541 I>V No ClinGen
ExAC
gnomAD
CA357162596
rs1255291620
544 D>H No ClinGen
gnomAD
rs1362144440
CA357162558
547 S>R No ClinGen
gnomAD
CA99626817
rs1044100600
548 F>I No ClinGen
TOPMed
CA2983618
rs768113639
549 D>H No ClinGen
ExAC
gnomAD
rs1360098549
CA357162533
551 P>A No ClinGen
TOPMed
rs1228394520
CA357162531
551 P>R No ClinGen
gnomAD
rs980989962
CA99626790
552 T>A No ClinGen
TOPMed
CA357162527
rs980989962
552 T>S No ClinGen
TOPMed
TCGA novel 556 C>Y Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
COSM2157208
rs745754260
CA2983614
COSM2157207
557 V>I Variant assessed as Somatic; 0.0 impact. central_nervous_system [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
ExAC
NCI-TCGA
TOPMed
gnomAD
rs1372843897
CA357162457
562 E>G No ClinGen
TOPMed
CA357162410
rs1291510415
569 R>* No ClinGen
gnomAD
CA2983613
rs780864218
569 R>L No ClinGen
ExAC
TOPMed
gnomAD
CA357162408
rs780864218
569 R>Q Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
CA2983612
rs757069865
571 G>R No ClinGen
ExAC
gnomAD
rs1417333846
CA357162384
573 I>M Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
gnomAD
CA2983610
rs764354837
576 D>E No ClinGen
ExAC
gnomAD
CA2983611
COSM3428702
COSM3428701
rs751785646
576 D>Y large_intestine Variant assessed as Somatic; impact. [Cosmic, NCI-TCGA] No ClinGen
cosmic curated
ExAC
NCI-TCGA
rs1359290257
CA357162362
577 L>M No ClinGen
TOPMed
gnomAD
TCGA novel 578 K>N Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
TCGA novel 578 K>Q Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA99626649
rs992380379
579 P>L No ClinGen
TOPMed
gnomAD
rs992380379
CA357162345
579 P>Q No ClinGen
TOPMed
gnomAD
rs140303803
CA99626657
COSM107928
579 P>S skin [Cosmic] No ClinGen
cosmic curated
Ensembl
CA2983609
rs758512568
580 E>D No ClinGen
ExAC
gnomAD
rs1490941351
CA357162289
587 E>D No ClinGen
gnomAD
CA357162285
rs1293006166
588 G>C No ClinGen
gnomAD
rs1560543898
CA357161227
594 D>Y No ClinGen
Ensembl
rs766890690
CA2983586
598 A>V No ClinGen
ExAC
gnomAD
TCGA novel 599 K>N Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1337369957
CA357161178
600 K>N No ClinGen
gnomAD
CA2983584
rs561520112
601 I>T No ClinGen
1000Genomes
ExAC
gnomAD
rs1395422824
CA357161159
603 S>F No ClinGen
gnomAD
rs1177991190
CA357161143
606 K>E No ClinGen
TOPMed
gnomAD
CA357161135
rs1560543829
607 T>A No ClinGen
Ensembl
CA99606445
rs770087958
614 P>A No ClinGen
Ensembl
CA357161051
rs1410771687
619 P>L No ClinGen
gnomAD
TCGA novel 621 V>F Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs769485643
CA2983580
622 I>V No ClinGen
ExAC
gnomAD
CA2983579
rs759061992
623 L>F No ClinGen
ExAC
gnomAD
rs899871798
CA99606409
624 N>K No ClinGen
TOPMed
CA2983577
rs770931091
624 N>S No ClinGen
ExAC
TOPMed
gnomAD
rs776473582
CA2983578
624 N>Y No ClinGen
ExAC
gnomAD
CA357161018
rs1442402207
625 K>Q No ClinGen
gnomAD
CA99606405
COSM352162
rs1041060556
COSM352163
627 H>R lung [Cosmic] No ClinGen
cosmic curated
TOPMed
CA357161002
rs1236273798
627 H>Y No ClinGen
TOPMed
rs746868914
CA2983576
628 D>G No ClinGen
ExAC
rs112798364
CA99606395
630 S>G No ClinGen
Ensembl
rs145797166
CA2983573
631 V>A No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs372904531
CA2983574
631 V>M No ClinGen
ESP
ExAC
gnomAD
CA2983572
COSM1540727
COSM1540726
rs779096403
632 D>Y lung Variant assessed as Somatic; 0.0 impact. [Cosmic, NCI-TCGA] No ClinGen
cosmic curated
ExAC
NCI-TCGA
TOPMed
gnomAD
CA99606381
rs867153918
633 F>I No ClinGen
Ensembl
CA2983570
rs753927835
633 F>L No ClinGen
ExAC
CA2983571
rs755101378
633 F>Y No ClinGen
ExAC
CA2983568
rs779960963
634 W>* No ClinGen
ExAC
CA2983569
rs749314930
634 W>* No ClinGen
ExAC
gnomAD
CA357160952
rs1285670222
634 W>C No ClinGen
TOPMed
CA553083457
rs1218620628
634 W>R No ClinGen
gnomAD
CA2983565
rs752793942
635 S>* No ClinGen
ExAC
rs760444787
CA2983564
635 S>* No ClinGen
ExAC
gnomAD
rs1243906464
CA357160945
636 L>M No ClinGen
TOPMed
gnomAD
rs768000424
CA2983561
640 V>A No ClinGen
ExAC
rs762265808
CA2983560
641 Y>H No ClinGen
ExAC
gnomAD
rs752445893
CA2983559
643 L>F No ClinGen
ExAC
gnomAD
rs575558482
CA2983557
645 T>M Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
1000Genomes
ExAC
NCI-TCGA
TOPMed
gnomAD
CA99603102
rs868261975
650 F>L No ClinGen
Ensembl
CA357160838
rs1184886233
651 S>C No ClinGen
gnomAD
rs761702360
CA2983532
653 V>I No ClinGen
ExAC
gnomAD
CA357160822
rs1242923777
654 D>A No ClinGen
gnomAD
rs988607517
CA99603089
654 D>Y No ClinGen
TOPMed
TCGA novel 655 Q>K Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs774157529
CA2983531
658 T>S No ClinGen
ExAC
gnomAD
rs1489798291
CA357160783
659 Y>C No ClinGen
gnomAD
CA357160757
rs1357365730
663 L>I No ClinGen
gnomAD
rs370269168
CA99603042
666 I>T No ClinGen
ESP
gnomAD
TCGA novel 668 K>R Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA357160710
rs1434216778
669 M>R No ClinGen
Ensembl
CA357160714
rs1560539719
669 M>V No ClinGen
Ensembl
CA2983528
rs190673928
671 F>L No ClinGen
1000Genomes
ExAC
gnomAD
CA99603033
rs1000243529
673 R>T No ClinGen
TOPMed
TCGA novel 675 I>V Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA2983526
rs745909792
676 T>A No ClinGen
ExAC
gnomAD
CA2983525
rs781379008
676 T>R No ClinGen
ExAC
TOPMed
gnomAD
CA99603016
rs867510159
677 R>* Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
gnomAD
CA357160658
rs757860585
677 R>L No ClinGen
ExAC
TOPMed
gnomAD
CA357160659
rs757860585
677 R>P No ClinGen
ExAC
TOPMed
gnomAD
CA2983524
rs757860585
677 R>Q No ClinGen
ExAC
TOPMed
gnomAD
CA2983523
rs760133321
678 R>* Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
CA2983522
rs778199944
678 R>Q Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
TCGA novel 682 L>F Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA2983520
rs753582287
684 R>L No ClinGen
ExAC
TOPMed
gnomAD
CA357160616
rs753582287
684 R>Q Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
TCGA novel 684 R>W Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs987651040
CA99602959
685 R>K No ClinGen
TOPMed
gnomAD
rs953648423
CA99602943
686 L>F No ClinGen
Ensembl
rs747582690
CA2983502
688 R>S No ClinGen
ExAC
gnomAD
rs934758645
CA99601839
690 N>S No ClinGen
Ensembl
CA2983501
rs778125868
691 P>T No ClinGen
ExAC
gnomAD
TCGA novel 694 R>M Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA357159895
rs1263357804
694 R>S No ClinGen
TOPMed
gnomAD
CA2983499
rs748432620
CA2983500
697 N>K No ClinGen
ExAC
TOPMed
gnomAD
rs376309288
CA2983497
699 K>T No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA2983496
rs368664749
702 I>M No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs1374742486
CA357159825
703 N>S No ClinGen
gnomAD
rs780685462
CA357159817
704 D>G No ClinGen
ExAC
gnomAD
CA2983495
rs780685462
704 D>V No ClinGen
ExAC
gnomAD
rs924591161
CA99601757
705 I>V No ClinGen
Ensembl
CA357411273
rs1291561738
713 G>D Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
VAR_040609 716 W>R a colorectal adenocarcinoma sample; somatic mutation [UniProt] No UniProt
rs1292504383
CA357411232
718 G>A No ClinGen
gnomAD
rs1292504383
CA357411234
718 G>V No ClinGen
gnomAD
rs748642381
CA2983462
719 L>V No ClinGen
ExAC
gnomAD
rs1376288803
CA357411223
720 K>R No ClinGen
gnomAD
CA357411215
rs1324820305
721 A>G No ClinGen
gnomAD
CA2983459
rs140080099
722 R>G No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs780810215
CA2983458
722 R>Q No ClinGen
ExAC
TOPMed
gnomAD
CA2983460
rs140080099
722 R>W No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA2983456
rs751059878
723 S>R No ClinGen
ExAC
gnomAD
TCGA novel 724 L>H Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA2983454
rs758280225
729 Q>E No ClinGen
ExAC
gnomAD
CA357411166
rs1460014049
730 R>G No ClinGen
TOPMed
gnomAD
rs894813536
CA100038411
735 P>H No ClinGen
TOPMed
rs766229697
CA2983429
736 I>V No ClinGen
ExAC
TOPMed
gnomAD
CA357411105
rs1560524867
737 D>G No ClinGen
Ensembl
TCGA novel 737 D>Y Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1451261429
CA357411098
738 H>P No ClinGen
gnomAD
CA100038408
rs965933216
739 S>G No ClinGen
Ensembl
CA357411090
rs1338254370
739 S>N No ClinGen
gnomAD
rs756304665
CA357411064
742 D>E No ClinGen
ExAC
TOPMed
gnomAD
rs750593016
CA2983427
744 Y>H No ClinGen
ExAC
gnomAD
CA357411052
rs1422157793
744 Y>S No ClinGen
gnomAD
CA2983426
rs562688407
745 P>L No ClinGen
1000Genomes
ExAC
gnomAD
CA357411039
rs1560524806
746 P>R No ClinGen
Ensembl
rs1017752528
CA100038403
746 P>S No ClinGen
TOPMed
rs1007287261
CA100038398
755 L>P No ClinGen
TOPMed
rs1007287261
CA100038400
755 L>Q No ClinGen
TOPMed
CA100038393
rs868077737
COSM163747
COSM163748
761 D>N NS [Cosmic] No ClinGen
cosmic curated
Ensembl
rs1241403547
CA357410917
763 F>W No ClinGen
gnomAD

2 associated diseases with Q13237

[MIM: 619638]: Spondylometaphyseal dysplasia, Pagnamenta type (SMDP)

A form of spondylometaphyseal dysplasia, a group of short stature disorders distinguished by abnormalities in the vertebrae and the metaphyses of the tubular bones. SMDP is an autosomal recessive form characterized by short stature and mild platyspondyly with no disproportion between the limbs. Mild metaphyseal changes are present. {ECO:0000269|PubMed:34782440}. Note=The disease is caused by variants affecting the gene represented in this entry.

[MIM: 619636]: Acromesomelic dysplasia 4 (AMD4)

A form of acromesomelic dysplasia, a skeletal disorder characterized by short stature, very short limbs and hand/foot malformations. The severity of limb abnormalities increases from proximal to distal with profoundly affected hands and feet showing brachydactyly and/or rudimentary fingers (knob-like fingers). AMD4 radiographic hallmarks include mild to moderate platyspondyly, moderate brachydactyly, iliac flaring, and metaphyseal alterations of the long bones that progressively increase with age. AMD4 inheritance is autosomal recessive. {ECO:0000269|PubMed:33106379, ECO:0000269|PubMed:34782440}. Note=The disease is caused by variants affecting the gene represented in this entry.

Without disease ID
  • A form of spondylometaphyseal dysplasia, a group of short stature disorders distinguished by abnormalities in the vertebrae and the metaphyses of the tubular bones. SMDP is an autosomal recessive form characterized by short stature and mild platyspondyly with no disproportion between the limbs. Mild metaphyseal changes are present. {ECO:0000269|PubMed:34782440}. Note=The disease is caused by variants affecting the gene represented in this entry.
  • A form of acromesomelic dysplasia, a skeletal disorder characterized by short stature, very short limbs and hand/foot malformations. The severity of limb abnormalities increases from proximal to distal with profoundly affected hands and feet showing brachydactyly and/or rudimentary fingers (knob-like fingers). AMD4 radiographic hallmarks include mild to moderate platyspondyly, moderate brachydactyly, iliac flaring, and metaphyseal alterations of the long bones that progressively increase with age. AMD4 inheritance is autosomal recessive. {ECO:0000269|PubMed:33106379, ECO:0000269|PubMed:34782440}. Note=The disease is caused by variants affecting the gene represented in this entry.

11 regional properties for Q13237

Type Name Position InterPro Accession
domain Cyclic nucleotide-binding domain 168 - 284 IPR000595-1
domain Cyclic nucleotide-binding domain 286 - 409 IPR000595-2
domain Protein kinase domain 453 - 711 IPR000719
domain AGC-kinase, C-terminal 712 - 762 IPR000961
active_site Serine/threonine-protein kinase, active site 572 - 584 IPR008271
binding_site Protein kinase, ATP binding site 459 - 486 IPR017441
conserved_site Cyclic nucleotide-binding, conserved site 195 - 211 IPR018488-1
conserved_site Cyclic nucleotide-binding, conserved site 231 - 248 IPR018488-2
conserved_site Cyclic nucleotide-binding, conserved site 313 - 329 IPR018488-3
conserved_site Cyclic nucleotide-binding, conserved site 355 - 372 IPR018488-4
domain cGMP-dependent protein kinase, catalytic domain 459 - 718 IPR035014

Functions

Description
EC Number 2.7.11.12 Protein-serine/threonine kinases
Subcellular Localization
  • Apical cell membrane ; Lipid-anchor
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

3 GO annotations of cellular component

Name Definition
apical plasma membrane The region of the plasma membrane located at the apical end of the cell.
cytosol The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
nuclear membrane Either of the lipid bilayers that surround the nucleus and form the nuclear envelope; excludes the intermembrane space.

7 GO annotations of molecular function

Name Definition
ATP binding Binding to ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator.
cGMP binding Binding to cGMP, the nucleotide cyclic GMP (guanosine 3',5'-cyclophosphate).
cGMP-dependent protein kinase activity cGMP dependent catalysis of the reaction: ATP + a protein = ADP + a phosphoprotein.
identical protein binding Binding to an identical protein or proteins.
mitogen-activated protein kinase binding Binding to a mitogen-activated protein kinase.
protein kinase activity Catalysis of the phosphorylation of an amino acid residue in a protein, usually according to the reaction: a protein + ATP = a phosphoprotein + ADP.
protein serine kinase activity Catalysis of the reactions: ATP + protein serine = ADP + protein serine phosphate.

8 GO annotations of biological process

Name Definition
negative regulation of chloride transport Any process that stops, prevents or reduces the frequency, rate or extent of chloride transport.
negative regulation of chondrocyte proliferation Any process that stops, prevents, or reduces the frequency, rate or extent of the multiplication or reproduction of chondrocytes by cell division, resulting in the expansion of their population. A chondrocyte is a polymorphic cell that forms cartilage.
peptidyl-serine autophosphorylation The phosphorylation by a protein of one or more of its own serine amino acid residues, or a serine residue on an identical protein.
protein localization to plasma membrane A process in which a protein is transported to, or maintained in, a specific location in the plasma membrane.
protein phosphorylation The process of introducing a phosphate group on to a protein.
regulation of chondrocyte differentiation Any process that modulates the frequency, rate or extent of chondrocyte differentiation.
signal transduction The cellular process in which a signal is conveyed to trigger a change in the activity or state of a cell. Signal transduction begins with reception of a signal (e.g. a ligand binding to a receptor or receptor activation by a stimulus such as light), or for signal transduction in the absence of ligand, signal-withdrawal or the activity of a constitutively active receptor. Signal transduction ends with regulation of a downstream cellular process, e.g. regulation of transcription or regulation of a metabolic process. Signal transduction covers signaling from receptors located on the surface of the cell and signaling via molecules located within the cell. For signaling between cells, signal transduction is restricted to events at and within the receiving cell.
tetrahydrobiopterin metabolic process The chemical reactions and pathways involving tetrahydrobiopterin, the reduced form of biopterin (2-amino-4-hydroxy-6-(1,2-dihydroxypropyl)-pteridine). It functions as a hydroxylation coenzyme, e.g. in the conversion of phenylalanine to tyrosine.

8 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
P00516 PRKG1 cGMP-dependent protein kinase 1 Bos taurus (Bovine) SS
Q03043 for cGMP-dependent protein kinase, isozyme 2 forms cD4/T1/T3A/T3B Drosophila melanogaster (Fruit fly) SS
P17612 PRKACA cAMP-dependent protein kinase catalytic subunit alpha Homo sapiens (Human) PR
Q13976 PRKG1 cGMP-dependent protein kinase 1 Homo sapiens (Human) EV
P0C605 Prkg1 cGMP-dependent protein kinase 1 Mus musculus (Mouse) SS
Q61410 Prkg2 cGMP-dependent protein kinase 2 Mus musculus (Mouse) PR
Q64595 Prkg2 cGMP-dependent protein kinase 2 Rattus norvegicus (Rat) PR
O76360 egl-4 cGMP-dependent protein kinase egl-4 Caenorhabditis elegans PR
10 20 30 40 50 60
MGNGSVKPKH SKHPDGHSGN LTTDALRNKV TELERELRRK DAEIQEREYH LKELREQLSK
70 80 90 100 110 120
QTVAIAELTE ELQNKCIQLN KLQDVVHMQG GSPLQASPDK VPLEVHRKTS GLVSLHSRRG
130 140 150 160 170 180
AKAGVSAEPT TRTYDLNKPP EFSFEKARVR KDSSEKKLIT DALNKNQFLK RLDPQQIKDM
190 200 210 220 230 240
VECMYGRNYQ QGSYIIKQGE PGNHIFVLAE GRLEVFQGEK LLSSIPMWTT FGELAILYNC
250 260 270 280 290 300
TRTASVKAIT NVKTWALDRE VFQNIMRRTA QARDEQYRNF LRSVSLLKNL PEDKLTKIID
310 320 330 340 350 360
CLEVEYYDKG DYIIREGEEG STFFILAKGK VKVTQSTEGH DQPQLIKTLQ KGEYFGEKAL
370 380 390 400 410 420
ISDDVRSANI IAEENDVACL VIDRETFNQT VGTFEELQKY LEGYVANLNR DDEKRHAKRS
430 440 450 460 470 480
MSNWKLSKAL SLEMIQLKEK VARFSSSSPF QNLEIIATLG VGGFGRVELV KVKNENVAFA
490 500 510 520 530 540
MKCIRKKHIV DTKQQEHVYS EKRILEELCS PFIVKLYRTF KDNKYVYMLL EACLGGELWS
550 560 570 580 590 600
ILRDRGSFDE PTSKFCVACV TEAFDYLHRL GIIYRDLKPE NLILDAEGYL KLVDFGFAKK
610 620 630 640 650 660
IGSGQKTWTF CGTPEYVAPE VILNKGHDFS VDFWSLGILV YELLTGNPPF SGVDQMMTYN
670 680 690 700 710 720
LILKGIEKMD FPRKITRRPE DLIRRLCRQN PTERLGNLKN GINDIKKHRW LNGFNWEGLK
730 740 750 760
ARSLPSPLQR ELKGPIDHSY FDKYPPEKGM PPDELSGWDK DF